Literature DB >> 5394454

[Pharmacology of HB 419, a new strongly effective oral antidiabetic].

A Bänder, W Pfaff, F H Schmidt, H Stork, H G Schröder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5394454

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN： 0004-4172


× No keyword cloud information.
  6 in total

1.  [Effect of adrenergic blocking agents on the acute tolbutamide response in dogs].

Authors:  A Sirek; O V Sirek; F Smigura; K Przybylska
Journal:  Acta Diabetol Lat       Date:  1970 Sep-Oct

2.  Extrapancreatic and pancreatic actions of glibenclamide in rats.

Authors:  W Heptner; A Zermatten; H M Kellner; O Christ; J P Felber
Journal:  Diabetologia       Date:  1977-08       Impact factor: 10.122

3.  The pancreatic -cell recognition of insulin secretagogues. IV. Islet uptake of sulfonylureas.

Authors:  B Hellman; J Sehlin; I B Täljedal
Journal:  Diabetologia       Date:  1973-06       Impact factor: 10.122

Review 4.  Glibenclamide: a review.

Authors: 
Journal:  Drugs       Date:  1971       Impact factor: 9.546

5.  [Evaluation of the prolonged treatment of patients with the adult type of diabetes with glibenclamide (HB 419)].

Authors:  C R Aiello; D Turner; L Schwarzstein; R E Adrián; E A De Turner; N J Aparicio
Journal:  Acta Diabetol Lat       Date:  1971 Sep-Oct

Review 6.  Acute and chronic animal models for the evaluation of anti-diabetic agents.

Authors:  Suresh Kumar; Rajeshwar Singh; Neeru Vasudeva; Sunil Sharma
Journal:  Cardiovasc Diabetol       Date:  2012-01-19       Impact factor: 9.951
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.